 SAN DIEGO, April 05, 2021 GLOBE NEWSWIRE -- Maravai LifeSciences Holdings, Inc. Maravai NASDAQ: MRVI, a global provider of life science reagents and services to researchers and biotech innovators, today announced the commencement of a public offering of its Class A common stock by certain selling stockholders. The selling stockholders are offering 15,000,000 shares of Maravais Class A common stock pursuant to a registration statement on Form S-1 the Registration Statement filed with the Securities and Exchange Commission the SEC. The selling stockholders intend to grant the underwriters a 30-day option to purchase up to an additional 2,250,000 shares of Maravais Class A common stock. 